Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
related discipline Required Other None Additional Preferred Experience working in one or more of the following areas: Longitudinal data analysis Predictive modeling/machine learning models Biostatistics
-
following: life cycle assessment, life-cycle cost analysis, pavement simulation, machine learning, deep reinforcement learning, and/or physics-informed modeling frameworks; and demonstrated ability to
-
: Machine learning/predictive modeling for longitudinal data analysis or large language models. Strong motivation in the development and application of digital twins, particularly in health and biomedical
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 19 hours ago
integrating mechanistic modeling and machine learning methods to analyze and predict drug properties, patient responses, and benefit-risk profiles, using real-world and regulatory datasets. This
-
combining state-of-the-art machine learning with physicochemical knowledge and molecular modeling. Representative publications from our group include: https://doi.org/10.1038/s41467-025-63947-5 https
-
combining state-of-the-art machine learning with physicochemical knowledge and molecular modeling. Representative publications from our group include: https://doi.org/10.1038/s41467-025-63947-5 https
-
research in numerical methods for partial differential equations and machine learning methods for physics-based modeling. Equal Employment Opportunity Statement All qualified applicants will receive
-
machine learning, reduced-order modeling, or data-driven modeling of physical systems. You will conduct research on the development of fast, trustworthy, and data-efficient surrogate models that
-
University of California, San Diego | Estancia de San Diego, Guanajuato | Mexico | about 8 hours ago
• Develop and apply reduced-order modeling approaches using spatiotemporal decompositions of large high-resolution simulation datasets. • Develop and train machine learning architectures using reduced
-
approaches for drug design by combining state-of-the-art machine learning with physicochemical knowledge and molecular modeling. Representative publications from our group include: https://doi.org/10.1038